Invention Grant
- Patent Title: Vaccine to pathogenic immune activation cells during infections
-
Application No.: US17360129Application Date: 2021-06-28
-
Publication No.: US11957748B2Publication Date: 2024-04-16
- Inventor: Daniel Zagury
- Applicant: 21C Bio
- Applicant Address: FR Paris
- Assignee: 21 C Bio
- Current Assignee: 21 C Bio
- Current Assignee Address: FR Paris
- Agency: Maier & Maier, PLLC
- Priority: EP 189405 2019.07.31
- Main IPC: A61P31/18
- IPC: A61P31/18 ; A61K38/21 ; A61K39/00 ; A61K39/09 ; A61K39/12 ; A61K39/21 ; A61P37/04 ; C12N7/00 ; A61K45/06

Abstract:
A method for preventing an infectious disease in a subject in need thereof. In particular the method includes the administration of a combination, pharmaceutical combination, medicament or kit-of-parts including a first part including a CD8 vaccine specific for at least one infectious disease-related antigen, optionally a second part including an interferon alpha blocking agent, and a third part including a type III interferon and/or an agent stimulating the production of type III interferon.
Public/Granted literature
- US20210322538A1 VACCINE TO PATHOGENIC IMMUNE ACTIVATION CELLS DURING INFECTIONS Public/Granted day:2021-10-21
Information query